Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Unsafe Sex | 1 | 2016 | 238 | 0.450 |
Why?
|
| Vasoactive Intestinal Peptide | 3 | 2008 | 180 | 0.430 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2018 | 636 | 0.430 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2018 | 572 | 0.430 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 983 | 0.370 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1527 | 0.320 |
Why?
|
| Communicable Diseases | 3 | 2022 | 875 | 0.300 |
Why?
|
| Reversal Learning | 1 | 2008 | 57 | 0.290 |
Why?
|
| Homosexuality, Male | 1 | 2016 | 1334 | 0.290 |
Why?
|
| Social Behavior | 2 | 2008 | 1135 | 0.230 |
Why?
|
| Smell | 4 | 2006 | 259 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3205 | 0.190 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2024 | 343 | 0.190 |
Why?
|
| Anti-HIV Agents | 1 | 2016 | 4527 | 0.170 |
Why?
|
| Sulbactam | 1 | 2018 | 31 | 0.160 |
Why?
|
| Ampicillin | 1 | 2018 | 136 | 0.150 |
Why?
|
| Cefazolin | 1 | 2018 | 94 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2008 | 2639 | 0.140 |
Why?
|
| Bacteremia | 1 | 2024 | 979 | 0.140 |
Why?
|
| Metronidazole | 1 | 2018 | 232 | 0.140 |
Why?
|
| Muscular Disorders, Atrophic | 1 | 2016 | 24 | 0.140 |
Why?
|
| beta-Lactams | 1 | 2018 | 155 | 0.140 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2016 | 108 | 0.130 |
Why?
|
| Olfactory Bulb | 2 | 2006 | 198 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 12059 | 0.110 |
Why?
|
| Behavior, Animal | 4 | 2009 | 1878 | 0.110 |
Why?
|
| Habituation, Psychophysiologic | 3 | 2008 | 147 | 0.100 |
Why?
|
| Receptors, Androgen | 2 | 2016 | 1079 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2018 | 2048 | 0.100 |
Why?
|
| Curriculum | 3 | 2022 | 3743 | 0.100 |
Why?
|
| Sexual Partners | 1 | 2016 | 796 | 0.090 |
Why?
|
| Perioperative Care | 1 | 2018 | 1033 | 0.090 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 2373 | 0.090 |
Why?
|
| HIV Infections | 1 | 2016 | 17351 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2024 | 4234 | 0.080 |
Why?
|
| Neurulation | 1 | 2007 | 9 | 0.080 |
Why?
|
| Educational Status | 1 | 2016 | 2522 | 0.080 |
Why?
|
| Spatial Behavior | 1 | 2008 | 88 | 0.070 |
Why?
|
| Cholinergic Fibers | 1 | 2006 | 69 | 0.070 |
Why?
|
| Olfactory Pathways | 1 | 2008 | 132 | 0.070 |
Why?
|
| Peptides | 2 | 2016 | 4358 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 279 | 0.070 |
Why?
|
| Muscular Atrophy | 1 | 2009 | 334 | 0.070 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2009 | 258 | 0.070 |
Why?
|
| Maze Learning | 1 | 2008 | 483 | 0.070 |
Why?
|
| Reflex | 1 | 2008 | 376 | 0.060 |
Why?
|
| Afferent Pathways | 1 | 2006 | 298 | 0.060 |
Why?
|
| Boston | 1 | 2018 | 9326 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2024 | 22176 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2008 | 6228 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2006 | 629 | 0.060 |
Why?
|
| Logistic Models | 1 | 2018 | 13255 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1699 | 0.050 |
Why?
|
| Risk Factors | 3 | 2024 | 74206 | 0.050 |
Why?
|
| Fellowships and Scholarships | 2 | 2022 | 1117 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 1934 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2016 | 8181 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 4016 | 0.050 |
Why?
|
| Societies | 1 | 2021 | 108 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 957 | 0.050 |
Why?
|
| Fear | 1 | 2008 | 1476 | 0.040 |
Why?
|
| Preceptorship | 1 | 2018 | 56 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2008 | 14414 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2416 | 0.040 |
Why?
|
| Protein Denaturation | 1 | 2016 | 242 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2016 | 317 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2016 | 184 | 0.030 |
Why?
|
| Rats | 5 | 2016 | 23742 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 295 | 0.030 |
Why?
|
| Male | 8 | 2018 | 360804 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2007 | 4414 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 484 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4948 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2024 | 80636 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 577 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 870 | 0.030 |
Why?
|
| Middle Aged | 2 | 2018 | 220895 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 1139 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2016 | 8320 | 0.030 |
Why?
|
| Mice | 5 | 2016 | 81525 | 0.030 |
Why?
|
| United States | 2 | 2022 | 72334 | 0.030 |
Why?
|
| Animals | 9 | 2016 | 168459 | 0.020 |
Why?
|
| Time Factors | 3 | 2009 | 39967 | 0.020 |
Why?
|
| Humans | 8 | 2024 | 761504 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 11903 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9539 | 0.020 |
Why?
|
| Ligands | 1 | 2016 | 3272 | 0.020 |
Why?
|
| Aged | 2 | 2022 | 169289 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2009 | 129 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 59243 | 0.020 |
Why?
|
| Liver | 1 | 2024 | 7529 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 867 | 0.020 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2009 | 247 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4278 | 0.020 |
Why?
|
| Female | 4 | 2018 | 392644 | 0.020 |
Why?
|
| Nicotinic Antagonists | 1 | 2006 | 94 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 221177 | 0.020 |
Why?
|
| Receptors, Muscarinic | 1 | 2006 | 157 | 0.020 |
Why?
|
| Septal Nuclei | 1 | 2006 | 85 | 0.020 |
Why?
|
| Muscarinic Antagonists | 1 | 2006 | 135 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 231 | 0.020 |
Why?
|
| Serine | 1 | 2009 | 830 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 7407 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2009 | 899 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 2006 | 377 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2006 | 242 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2009 | 839 | 0.010 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 498 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 2009 | 1154 | 0.010 |
Why?
|
| Medicare | 1 | 2022 | 6770 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5336 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2006 | 495 | 0.010 |
Why?
|
| Transfection | 1 | 2009 | 5774 | 0.010 |
Why?
|
| Random Allocation | 1 | 2006 | 2395 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 894 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10445 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 1173 | 0.010 |
Why?
|
| Reaction Time | 1 | 2006 | 2082 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2865 | 0.010 |
Why?
|
| Action Potentials | 1 | 2006 | 1834 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3712 | 0.010 |
Why?
|
| Body Weight | 1 | 2008 | 4618 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23445 | 0.010 |
Why?
|
| Genotype | 1 | 2008 | 12990 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2006 | 6240 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 22169 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 9469 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 18252 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 9463 | 0.000 |
Why?
|
| Pregnancy | 1 | 2007 | 29874 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 30052 | 0.000 |
Why?
|
| Brain | 1 | 2007 | 27112 | 0.000 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_